Sign up now and fund within 24h to get A$10.
Claim It Now

Betashares Global Healthcare ETF - Currency Hedged

1 day chart

Get A$10 trading credit to start you off

Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.

Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.

T&Cs apply
Claim now
Get A$10 trading credit to start you off

About DRUG

Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Buy Australian shares starting with DRUG. Invest today with a CHESS-sponsored investing platform!

Sector

-

CEO

-

Industry

-

Website

betashares.com.au

Market Capitalisation

$0

Price-earnings ratio

8.95

Dividend yield

3.02%

High today

$8.35

Low today

$8.27

Open price

$8.35

52-week high

$9.17

52-week low

$7.68


Announcements





What is DRUG stock?

DRUG is an exchange-traded fund that invests in large-cap healthcare companies outside of Australia, both directly and through foreign currency forward contracts. 

Also known as BetaShares Global Healthcare ETF - Currency Hedged, DRUG is actively managed by BetaShares Capital Limited. It seeks to replicate the behaviour of the Nasdaq Global ex-Australia Healthcare Hedged AUD Index by investing in companies as per their weight in the index. DRUG’s returns are hedged to the Australian dollar.

Why is DRUG a currency-hedged ETF?

DRUG ETF is denominated in Australian dollars but equities within the fund are in foreign currencies.

By currency hedging, BetaShares locks down a set exchange rate for the future and lowers the effects and risks of exchange rate fluctuations on investments within DRUG.

How do I buy DRUG stock?

Stake offers a quick and easy way to purchase the DRUG ETF – along with 2,000+ other Australian stocks and ASX ETFs – for a brokerage fee of only A$3.

Stake is CHESS sponsored, meaning that when you invest in ASX stocks, you get a HIN (Holder Identification Number) and stocks are held in your name.

With Stake, you can be in the market in under 5 minutes, whether it's the ASX or Wall St. If you’re interested in building your portfolio by adding DRUG, sign up today.

Which stocks are in the DRUG ETF?

73.9% of DRUG is allocated to American healthcare stocks. Swiss, British, Japanese and Danish healthcare companies are also sizeable allocations at 9.4%, 4.9%, 3.3% and 3.2%, respectively.

Some of DRUG’s most prominent holdings include UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Pfizer Inc. (PFE), Roche (ROG), Eli Lilly & Company (LLY), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Novo Nordisk (NOVO-B) and Takeda Pharmaceutical Company (4502).

For a complete list of DRUG’s current holdings, click here.

Does DRUG pay a distribution?

Yes. As of 31 March 2022, DRUG stock’s distribution yield is 4.7%.

In FY2021, Betashares paid out a total of A$0.36644 per share. Historically, distributions have been paid twice a year, usually in January and July.

Is DRUG a good buy?

DRUG may be an appropriate buy for investors seeking quick, simple and cost-effective access to the world’s biggest healthcare companies. By purchasing DRUG, investors do not need to purchase individual healthcare stocks.

ETFs are usually considered long-term passive investments and the DRUG ETF is no exception. The fund has a low management cost of 0.57% p.a. In FY2021, the DRUG stock price achieved 22.34% growth.

Ready to start your investing journey with Stake?

Open an account

DRUG FAQs

  1. Find the right investing platform for you. To buy DRUG shares in Australia, you’ll need to open an account with an investing platform that offers the security. Try Stake, you can sign up in minutes.
  2. Fund your brokerage account. Once you are set up you can deposit into your account with different payment methods.
  3. Search for DRUG or Betashares Global Healthcare ETF - Currency Hedged. Find the stock by using the search function and go to the DRUG page.
  4. Place an order to buy DRUG. Press the ‘Buy’ button and choose an order type to place your trade. Depending on the order type, the trade will go through straight away or when a price target is hit.
  5. Monitor your portfolio. You’ve now purchased some DRUG shares. Stay on top of your portfolio and monitor its performance. You may be eligible for dividends and shareholder voting rights that affect your stock.

The ticker symbol for Betashares Global Healthcare ETF - Currency Hedged is DRUG.

One share of DRUG is valued at $8.27 as of 07 December 2024.

Yes, DRUG does pay dividends.

The dividend yield for DRUG is 3.02% as of 07 December 2024.

The most recent DRUG dividend distribution paid $0.22 per share on 16 July 2024.

The ex-dividend date of DRUG was 01 July 2024.

The Price to Earnings ratio of DRUG is 8.95.

The Earnings Per Share of DRUG is $0.93.

The Betashares Global Healthcare ETF - Currency Hedged 52-week high stock price is $9.17.

The Betashares Global Healthcare ETF - Currency Hedged 52-week low stock price is $7.68.

Yes, the Stake investing platform allows you to buy DRUG shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in DRUG
on Stake

Buy DRUG from A$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started
Canstar award phone
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
DRUG related stocks

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2024 Stake. All rights reserved.